Dr. George W. Sledge to join the board of Tessa

Singapore |  News | 0 Comment | 21 Dec, 2018

Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies for cancer patients, has announced that Dr. George W. Sledge, J...Read more

Strides gets USFDA nod for Lidocaine Ointment

Singapore |  News | 0 Comment | 19 Dec, 2018

Strides Pharma Science Limited (Strides) has announced that it step down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval forLidocaine Ointment ...Read more

Weight change in middle-aged and elderly Singaporean Chinese linked to increased mortality risk

Singapore |  News | 0 Comment | 18 Dec, 2018

Singapore – Both moderate-to-large weight gain and weight loss, defined as a change of 10% or more in weight, among middle-aged and elderly Chinese Singaporeans are linked to increase...Read more

“New innovations create meaningful barriers for competition”: Julie Tay

Singapore |  Opinion | By Priyanka Bajpai | 0 Comment | 17 Dec, 2018

Digital Orthodontics as a tool has the potential to replace the conventional methods in the future, because of its many business advantages including the ability to significantly shorten de...Read more

Cerveau announces Neuro PET imaging agent test in Singapore

Singapore |  News | 0 Comment | 17 Dec, 2018

Cerveau Technologies Inc., a partnership between Enigma Biomedical Group, Inc. and Sinotau Pharmaceutical Group, has announced that the Memory Aging and Cognition Centre (MACC) at the Natio...Read more

Prestige, Cipla unite to sell cancer biosimilar HD201

Singapore |  News | 0 Comment | 14 Dec, 2018

Prestige BioPharma (“Prestige”) has reached a licensing agreement with Cipla Limited (“Cipla”) for its trastuzumab biosimilar (HD201) under which Cipla will hav...Read more

NUS SINAPSE director elected as Fellow of prestigious NAI

Singapore |  News | 0 Comment | 12 Dec, 2018

Singapore– Professor Dean Ho, Director of the Singapore Institute for Neurotechnology (SINAPSE) at the National University of Singapore (NUS), has been elected as a Fellow of the Unit...Read more

Strides Vivimed JV receives approval for Albendazole Tablets

Singapore |  News | 0 Comment | 12 Dec, 2018

Strides  Pharma Science  Limited  (Strides)  has announced that its 50:50 JV Strides Vivimed Pte. Ltd, Singapore has received approval for Albendazole Tablets USP 200 mg...Read more

Duke-NUS highlights potential role of bioaerosol sampling to address airborne biological threats

Singapore |  News | 0 Comment | 11 Dec, 2018

Singapore – As a leading global city with a high population density, Singapore is vulnerable to the introduction of biological threats. Initiating an early emergency response to such ...Read more

Cerecin sponsors and presents at Alzheimer’s disease therapeutics

Singapore |  News | 0 Comment | 11 Dec, 2018

Singapore- Brain health-focused pharmaceutical company Cerecin, announced that it is a sponsor for the Alzheimer’s Disease Therapeutics: Alternatives to Amyloid Symposium to be h...Read more

Policymakers pledge to strengthen tobacco control & prevention of NCDs

Singapore |  News | 0 Comment | 10 Dec, 2018

Subnational leaders, mayors, government officials and civil society members gathered at the 3rd Asia Pacific Cities Alliance for Tobacco Control and NonCommunicable Diseases Prevention...Read more

Medidata wins recognition for Asia Pacific Clinical Trial IT Solutions Provider

Singapore |  News | 0 Comment | 10 Dec, 2018

Medidata was honored with the Asia Pacific Clinical Trial IT Solutions Provider of the Year Award at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet held at Shang...Read more

TauRx's LMTXs gets FDA Orphan-drug Designation

Singapore |  News | 0 Comment | 10 Dec, 2018

TauRx, a leader in neurodegenerative disease research, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to LMTX® for the "treatmen...Read more

Tychan begins Phase I Trials for first ever yellow fever drug

Singapore |  News | 0 Comment | 07 Dec, 2018

Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate drug for the treatment of Yellow Fever received investigatory new drug (...Read more

Innovative solutions to bridge unmet healthcare needs in Asia

Singapore |  News | 0 Comment | 07 Dec, 2018

Singapore- More than 100 people from 15 Asian countries who represented global public health, healthcare industry, digital tech, finance, nongovernmental organizations (NGOs), government an...Read more

AUM Biosciences acquires anti-cancer drug from A*STAR

Singapore |  News | 0 Comment | 06 Dec, 2018

AUM Biosciences (AUM), a Singapore headquartered oncology-focused biotechnology company, has licensed its first novel, highly selective anti-cancer drug, ETC-206, from A*STAR’s Experi...Read more

AUM Biosciences acquires novel anti-cancer drug

Singapore |  News | 0 Comment | 04 Dec, 2018

AUM Biosciences (AUM), a Singapore headquartered oncology-focused biotechnology company, has licensed its first novel, highly selective anti-cancer drug, ETC-206 , from A*STAR's Experimenta...Read more

MedAdvisor forms JV with healthcare giant Zuellig Pharma

Singapore |  News | 0 Comment | 03 Dec, 2018

MedAdvisor Limited, Australia’s leading digital medication management company, is pleased to announce it has signed a Heads of Agreement to form a joint venture with Zuellig Pharma Ho...Read more